Stick my neck on the line to state the above.Peter is sure that...

Stick my neck on the line to state the above.

Peter is sure that 2011 will be STI's year, and why not, there is so much teetering on the edge to make this company fire up.
Apart form world class people behind the scenes forming this company.

Firstly we can expect the Canadian production plant up and running in January with contracts in hand as well as our own products.

Funding from two corners (January)
- SPP - $6 mil
- Telemedicare - $15 mil

Telemedcare to establish a US based E-Health corporation that will globally commercialise these units.

HDA is further advanced than stated with prototype in hand months before expected and pre production units completed by Q1 with final testing through Q 2 - 3.
3 majors interested and has the potential to earn us multi millions and into billions of dollars.

R-salbutimol advancing to expectations and is highly likely to be commercialised in the near future............
and the list goes on

STI IMO will out preform every company on the ASX 2011 if all the above comes together as expected.
The imminent funding and production will be the catalyst as to how investors will treat the current value.

I believe in this company and wish it well for the 2011 year. STI has the potential to be many, many multiples of todays price.

This has been one hell of a ride.
Cheers and best wishes to all for the new year
Pachino